|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 100.70 SAR | -0.20% |
|
+2.44% | +6.00% |
| 02/02 | Morgan Stanley Begins Nahdi Medical's Coverage at Overweight | MT |
| 29/01 | Citi Upgrades Nahdi Medical to Buy | MT |
| Capitalization | 1.31TCr 349.76Cr 296.07Cr 271.35Cr 257Cr 477.21Cr 32TCr 498.93Cr 3.15TCr 1.25TCr 15TCr 1.28TCr 55TCr | P/E ratio 2025 * |
16.1x | P/E ratio 2026 * | 15x |
|---|---|---|---|---|---|
| Enterprise value | 1.44TCr 382.76Cr 324.01Cr 296.96Cr 281.25Cr 522.24Cr 35TCr 546.01Cr 3.45TCr 1.37TCr 17TCr 1.41TCr 60TCr | EV / Sales 2025 * |
1.41x | EV / Sales 2026 * | 1.27x |
| Free-Float |
36.92% | Yield 2025 * |
5.37% | Yield 2026 * | 5.63% |
| 1 day | -0.20% | ||
| 1 week | +2.44% | ||
| Current month | +2.18% | ||
| 1 month | +9.34% | ||
| 3 months | -10.09% | ||
| 6 months | -18.46% | ||
| Current year | +6.00% |
| 1 week | 97.45 |  | 102.3 |
| 1 month | 91 | | 102.3 |
| Current year | 91 | | 102.3 |
| 1 year | 91 | | 132.1 |
| 3 years | 91 | | 190 |
| 5 years | 91 | | 209.4 |
| 10 years | 91 | | 209.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yasser Joharji
CEO | Chief Executive Officer | 55 | 01/01/2014 |
| Director of Finance/CFO | 52 | - | |
Khalid Tadlaoui
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/01/2011 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 75 | 01/01/2021 | |
| Director/Board Member | 64 | 18/06/1986 | |
| Director/Board Member | 73 | 01/01/2021 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.20% | +2.44% | -15.09% | -45.57% | 349.76Cr | |
| -2.47% | -6.48% | +82.28% | -4.29% | 2.43TCr | |
| -1.61% | -6.44% | +59.69% | -3.79% | 1.26TCr | |
| +1.29% | +6.21% | +18.83% | +24.94% | 667.09Cr | |
| +1.37% | +0.04% | -8.17% | +20.25% | 476.9Cr | |
| -0.71% | +5.44% | +7.42% | -25.09% | 440.13Cr | |
| -1.31% | -1.80% | +38.90% | -34.86% | 322.34Cr | |
| -0.57% | -2.08% | -7.83% | +47.44% | 287.29Cr | |
| Average | -0.53% | +0.75% | +22.00% | -2.62% | 779.34Cr | |
| Weighted average by Cap. | -1.20% | -2.31% | +46.86% | -2.16% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 1.02TCr 270.8Cr 229.24Cr 210.1Cr 198.98Cr 369.48Cr 25TCr 386.3Cr 2.44TCr 966.58Cr 12TCr 994.69Cr 43TCr | 1.11TCr 295.79Cr 250.38Cr 229.48Cr 217.34Cr 403.57Cr 27TCr 421.94Cr 2.67TCr 1.06TCr 13TCr 1.09TCr 46TCr |
| Net income | 82Cr 22Cr 19Cr 17Cr 16Cr 30Cr 1.98TCr 31Cr 197.06Cr 78Cr 953.25Cr 80Cr 3.43TCr | 88Cr 23Cr 20Cr 18Cr 17Cr 32Cr 2.12TCr 33Cr 210.96Cr 84Cr 1.02TCr 86Cr 3.67TCr |
| Net Debt | 123.77Cr 33Cr 28Cr 26Cr 24Cr 45Cr 2.99TCr 47Cr 297.55Cr 117.8Cr 1.44TCr 121.22Cr 5.18TCr | 102.56Cr 27Cr 23Cr 21Cr 20Cr 37Cr 2.48TCr 39Cr 246.55Cr 98Cr 1.19TCr 100.45Cr 4.29TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/26/08 | 100.70 ﷼ | -0.20% | 51,704 |
| 05/26/05 | 100.90 ﷼ | +0.10% | 2,47,391 |
| 04/26/04 | 100.80 ﷼ | +0.90% | 1,97,993 |
| 03/26/03 | 99.90 ﷼ | -1.96% | 2,63,833 |
| 02/26/02 | 101.90 ﷼ | +3.66% | 3,52,120 |
Delayed Quote Saudi Arabian S.E., February 08, 2026 at 01:56 pm IST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 4164 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition